|
1 |
Experimental model and novel therapeutic targets for non-alcoholic fatty liver disease development
Yujin Jin, Kyung-Sun Heo
|
|
2 |
Exercise Capacity and Pulmonary Capacitance Are Attenuated in Patients with Nonalcoholic Steatohepatitis
Joshua Donkor, Alex R. Carlson, Briana L. Ziegler, Jessica I. Johnston, Jinkyung Cho, Bruce D. Johnson, Chul-Ho Kim
|
|
3 |
Beneficial Effects of a Curcumin Derivative and Transforming Growth Factor-β Receptor I Inhibitor Combination on Nonalcoholic Steatohepatitis
Kyung Bong Ha, Eun Soo Lee, Na Won Park, Su Ho Jo, Soyeon Shim, Dae-Kee Kim, Chan Mug Ahn, Choon Hee Chung
Diabetes Metab J.2023;47(4):500-513. Published online 2023 April 25
DOI: http://dx.doi.org/10.4093/dmj.2022.0110
|
|
4 |
Fatty Liver & Diabetes Statistics in Korea: Nationwide Data 2009 to 2017
Eugene Han, Kyung-Do Han, Yong-ho Lee, Kyung-Soo Kim, Sangmo Hong, Jung Hwan Park, Cheol-Young Park
Diabetes Metab J.2023;47(3):347-355. Published online 2023 March 29
DOI: http://dx.doi.org/10.4093/dmj.2022.0444
|
|
5 |
Performance of Simple Fibrosis Score in Non-Alcoholic Fatty Liver Disease with and without Type 2 Diabetes
Seung Min Chung, Min Kyu Kang, Jun Sung Moon, Jung Gil Park
Endocrinol Metab.2023;38(2):277-281. Published online 2023 March 13
DOI: http://dx.doi.org/10.3803/EnM.2022.1635
|
|
6 |
Non-alcoholic fatty liver disease-related hepatocellular carcinoma
Darine Daher, Karim Seif El Dahan, Amit G. Singal
J Liver Cancer.2023;23(1):127-142. Published online 2023 February 9
DOI: http://dx.doi.org/10.17998/jlc.2022.12.30
|
|
7 |
Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography
Hwi Seung Kim, Jiwoo Lee, Eun Hee Kim, Min Jung Lee, In Young Bae, Woo Je Lee, Joong-Yeol Park, Hong-Kyu Kim, Chang Hee Jung
Diabetes Metab J.2023;47(1):104-117. Published online 2023 January 26
DOI: http://dx.doi.org/10.4093/dmj.2022.0081
|
|
8 |
Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study
Kyung-Soo Kim, Sangmo Hong, Hong-Yup Ahn, Cheol-Young Park
Diabetes Metab J.2023;47(2):220-231. Published online 2023 January 12
DOI: http://dx.doi.org/10.4093/dmj.2021.0327
|
|
9 |
Radiomics Analysis of Magnetic Resonance Proton Density Fat Fraction for the Diagnosis of Hepatic Steatosis in Patients With Suspected Non-Alcoholic Fatty Liver Disease
Ki Choon Sim, Min Ju Kim, Yongwon Cho, Hyun Jin Kim, Beom Jin Park, Deuk Jae Sung, Na Yeon Han, Yeo Eun Han, Tae Hyung Kim, Yoo Jin Lee
|
|
10 |
Peroxisomal Fitness: A Potential Protective Mechanism of Fenofibrate against High Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice
Songling Jiang, Md Jamal Uddin, Xiaoying Yu, Lingjuan Piao, Debra Dorotea, Goo Taeg Oh, Hunjoo Ha
|
|
11 |
The Impact of Insulin Resistance on Hepatic Fibrosis among United States Adults with Non-Alcoholic Fatty Liver Disease: NHANES 2017 to 2018
Ji Cheol Bae, Lauren A. Beste, Kristina M. Utzschneider
|
|
12 |
Short-term outcome of bariatric surgery on nonalcoholic fatty liver disease: a Korean perspective
Ki Hyun Kim, Yoonhong Kim, Kwang Il Seo, Kyung Won Seo
|
|
13 |
Lifestyle Interventions for Non-Obese Patients Both with, and at Risk, of Non-Alcoholic Fatty Liver Disease
Xin-Lei Zhang, Ting-Yao Wang, Giovanni Targher, Christopher D. Byrne, Ming-Hua Zheng
|
|
14 |
State-of-the-Art Overview of the Pharmacological Treatment of Non-Alcoholic Steatohepatitis
Yongin Cho, Yong-ho Lee
Endocrinol Metab.2022;37(1):38-52. Published online 2022 February 28
DOI: http://dx.doi.org/10.3803/EnM.2022.102
|
|
15 |
Dulaglutide Ameliorates Palmitic Acid-Induced Hepatic Steatosis by Activating FAM3A Signaling Pathway
Jinmi Lee, Seok-Woo Hong, Min-Jeong Kim, Sun Joon Moon, Hyemi Kwon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee
Endocrinol Metab.2022;37(1):74-83. Published online 2022 February 9
DOI: http://dx.doi.org/10.3803/EnM.2021.1293
|
|
16 |
Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
Da Hea Seo, Young Ju Suh, Yongin Cho, Seong Hee Ahn, Seongha Seo, Seongbin Hong, Yong-ho Lee, Young Ju Choi, Eunjig Lee, So Hun Kim
Diabetes Metab J.2022;46(4):630-639. Published online 2022 January 26
DOI: http://dx.doi.org/10.4093/dmj.2021.0130
|
|
17 |
The Effects of PPAR Agonists on Atherosclerosis and Nonalcoholic Fatty Liver Disease in ApoE−/−FXR−/− Mice
Yenna Lee, Bo-Rahm Kim, Geun-Hyung Kang, Gwan Jae Lee, Young Joo Park, Haeryoung Kim, Hak Chul Jang, Sung Hee Choi
Endocrinol Metab.2021;36(6):1243-1253. Published online 2021 December 28
DOI: http://dx.doi.org/10.3803/EnM.2021.1100
|
|
18 |
Serotonergic Regulation of Hepatic Energy Metabolism
Jiwon Park, Wooju Jeong, Chahyeon Yun, Hail Kim, Chang-Myung Oh
Endocrinol Metab.2021;36(6):1151-1160. Published online 2021 December 16
DOI: http://dx.doi.org/10.3803/EnM.2021.1331
|
|
19 |
The Leg Fat to Total Fat Ratio Is Associated with Lower Risks of Non-Alcoholic Fatty Liver Disease and Less Severe Hepatic Fibrosis: Results from Nationwide Surveys (KNHANES 2008–2011)
Hyun Min Kim, Yong-ho Lee
Endocrinol Metab.2021;36(6):1232-1242. Published online 2021 November 23
DOI: http://dx.doi.org/10.3803/EnM.2021.1087
|
|
20 |
Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort
Hae Won Yoo, Hyun Young Jin, Dong Keon Yon, Maria Effenberger, Youn Ho Shin, So Young Kim, Jee Myung Yang, Min Seo Kim, Ai Koyanagi, Louis Jacob, Lee Smith, In Kyung Yoo, Jae Il Shin, Seung Won Lee
|
|